![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 14, 10160-10167, April 7, 2000
From the Experimental Immunology Branch, Building 10, Room 4B-36, NCI, National Institutes of Health, Bethesda, Maryland 20892
| |
ABSTRACT |
|---|
|
|
|---|
TAFII250, a component of the
general transcription factor, TFIID, is required for the transcription
of a subset of genes, including those involved in regulating cell cycle
progression. The tsBN462 cell line, with a temperature-sensitive
mutation of TAFII250, grows normally at 32 °C, but when
grown at 39.5 °C, it differentially arrests transcription of many,
but not all, genes. The present studies examine the basis for the
requirement for TAFII250. We show that the basal promoter
of a major histocompatibility complex class I gene requires
TAFII250. This dependence can be overcome by select
upstream regulatory elements but not by basal promoter elements. Thus,
the coactivator CIITA rescues the basal promoter from the requirement
for TAFII250, whereas introduction of a canonical TATAA box
does not. Similarly, the SV40 basal promoter is shown to require
TAFII250, and the presence of the 72-base pair enhancer
overcomes this requirement. Furthermore, the SV40 72-base pair enhancer
when placed upstream of the basal class I promoter renders it
independent of TAFII250. These data suggest that the
assembly of transcription initiation complexes is dynamic and can be
modulated by specific transcription factors.
Transcription of eukaryotic genes is initiated by the orderly
assembly of a series of general transcription factors (1). The general
transcription factor, TFIID, nucleates the assembly through the binding
of its component TBP to a TATAA box or other appropriate promoter
element. Other components of TFIID, the TBP-associated factors
(TAFs),1 recruit TFIIA and
TFIIB, which serves as a bridge to the RNA polymerase II complex, and
TFIIE, -F, and -H. As many as 12 distinct TAFs have been isolated and
their functions are beginning to be characterized (1). Through their
interactions with upstream transcription factors, the TAFs also
function as coactivators. In Drosophila, the TAFs appear to play a role
in promoter selectivity and are required to initiate at promoters that
lack a TBP binding site (2).
Recent evidence in yeast and mammalian cells indicates that not all
TAFs are essential for the transcription of all genes (3, 4). For
example, inactivation of yeast TAFII130, the homolog of
TAFII250, affects only a subset of genes. Similarly, a
point mutation of TAFII250 results in a
temperature-sensitive cell line, tsBN462. At the restrictive
temperature, cell cycle is arrested at G1, and
transcription of a set of cyclin genes is terminated (5-7). However,
other genes such as c-fos and c-myc continue to
be transcribed at the restrictive temperature (5-7).
Given the disparity in the requirements of different promoters for
TAFII250, it is of interest to determine whether the
primary role of TAFII250 is to function as a coactivator of
upstream transcription factors or as a general transcription factor
component that is necessary for assembling a preinitiation complex.
Various studies have suggested that promoter dependence on
TAFII250 is determined by upstream elements (7). Thus,
TAFII250-dependent transcription of the cyclin
A gene was mapped to an ATF binding site in the extended cyclin A
promoter (6). Similarly, an analysis of the cyclin D1 promoter
concluded that the TAFII250 mutation in the ts cells
affects the function of upstream activators, not the basal promoter
(7). Together, these studies suggest that the primary role of
TAFII250 is as a coactivator of upstream activators. However, at least for the cyclin D1 promoter, a function of
TAFII250 at the core promoter has not been excluded.
Furthermore, studies of both human cyclin A and several yeast promoters
have shown that the requirement for TAFII250 is determined
by the basal promoter; it has been suggested that TAFII250
is required for promoters that do not contain canonical TATAA boxes (7,
8).
The present studies were designed to assess the role(s) of
TAFII250 in regulating major histocompatibility complex
(MHC) class I expression. Unlike previously studied promoters, the
promoters of genes encoding MHC class I are ubiquitously expressed and
do not regulate cell cycle or growth. The MHC class I genes encode cell
surface molecules that, as dimers with We have previously reported that expression of the MHC class I gene,
PD1, depends upon a functional TAFII250 (12). In
particular, impairment of TAFII250 function, either through
inactivation in the tsBN462 cell line or through inactivation of the
intrinsic histone acetyltransferase activity, prevented transcription
from a PD1 promoter construct consisting of both the basal promoter and
upstream sequences. We now report that the basal promoter of PD1,
devoid of upstream regulatory elements, depends on a functional TAFII250 for transcription. This dependence is observed
both in vivo in tsBN462 cells and in in vitro
transcription assays with extract derived from these cells. The
requirement for TAFII250 is not overcome by introducing a
canonical TATAA box into the basal promoter. Indeed, mutational
analysis of the promoter indicates that TAFII250 does not
target a specific element within the promoter; all active basal
promoter constructs require TAFII250. The requirement for
TAFII250 can be overcome by select transcription factors
acting through upstream regulatory elements. In particular, the
coactivator CIITA, which activates class I promoter activity, can
effectively replace TAFII250 function. In contrast, USF1
and USF2, which also activate the class I promoter, do not overcome the
TAFII250 requirement.
We further show that the SV40 basal promoter is similarly dependent on
TAFII250. This dependence is overcome by the intact viral
72-bp enhancer and by the isolated octamer and AP1 subelements of the
enhancer. Interestingly, these viral enhancer elements can overcome the
TAFII250 dependence of the class I promoter when introduced upstream.
We conclude that TAFII250-independent transcription
requires the presence of specific upstream regulatory elements capable of recruiting appropriate coactivators. Furthermore, this leads to the
suggestion that an important activity of TAFII250, in
support of basal class I expression, is as a coactivator. Taken
together, the data suggest that the assembly of transcription
initiation complexes is a dynamic process that can be modulated by
specific transcription factors.
Cell Culture and Transfection--
The tsBN462 cells, containing
a point mutation in the TAFII250/CCG1 gene and derived from
BHK cells as described (13, 14) were obtained from T. Sekiguchi, Salk
Institute. The cells were maintained at 32 °C, 7.5% CO2
in Dulbecco's modified Eagle's medium (Biofluids) with 10% fetal
calf serum. Transfections were done by CaPO4, as described
previously, using 5 µg of DNA, unless otherwise indicated (12).
Following transfection, cells were incubated at 32 °C for 24 h,
after which time they were refed with fresh medium and either shifted
to 39.5 °C or left at 32 °C. After an additional 24 h, cells
were harvested and assayed for CAT activity, as described previously
(11). All activities were corrected for protein concentration. No
internal control for transfection efficiency could be used because the
activity of all of the viral promoters generally used to correct for
transfection efficiency increased in response temperature shift;
correcting to any of these would have artificially exaggerated the
effect of temperature shift on the class I and
DNA Constructs--
TAFII250 expression plasmid was
a gift of R. Tjian (University of California, Berkeley, CA). The HIVLTR
was pBennCAT (15). Rous sarcoma virus, murine leukemia virus, and AdML
promoter constructs were as described previously (12, 16). The PD1
deletion constructs and promoter mutations were described previously
(11, 17). The In Vitro Transcription--
Nuclear extracts were prepared from
tsBN462 cells and grown at either 32 °C or 39.5 °C, according to
the protocol of Dignam et al. (23). In vitro
transcription reactions contained 135 µg of nuclear extract, 2 µg
of Differential Sensitivity to a TAFII250 Mutation among
Different Promoters--
A series of cellular and viral promoters was
examined for their dependence on TAFII250. We tested three
ubiquitously expressed and related cellular promoters whose products
are involved in regulating immune responses: an MHC class Ia promoter,
PD1, whose gene encodes a classical transplantation antigen; an MHC
class Ib promoter, HLA-E, which governs expression of a nonclassical class I molecule; and the promoter of the
It has been suggested that TAFII250 dependence correlates
with the absence of a canonical TATAA box (7, 8). Consistent with this
suggestion, the PD1 promoter does not contain a canonical TATAA box and
depends on TAFII250. In contrast, the promoters of both the
Five viral promoter/enhancer constructs were also examined (murine
leukemia virus, SV40, Rous sarcoma virus, AdML, and HIVLTR); all were
as active, or more active, in the tsBN462 cells at the restrictive
temperature as at the permissive temperature (Table I). The findings
with the SV40 promoter are consistent with those previously reported by
others (5). To ensure that these results were not because of the use of
the common CAT reporter, the HIVLTR was tested with a luciferase
reporter, with the same outcome (data not shown). Thus, the viral
promoters do not require a functional TAFII250. The
remaining studies were directed at characterizing the basis of the PD1
promoter dependence on TAFII250.
In Vitro Transcription of the Class I Promoter Requires a
Functional TAFII250--
One of the effects of shifting
the tsBN462 cells to 39.5 °C, in addition to inactivating
TAFII250, is to arrest cells at G1 in the cell
cycle. Thus, in the above in vivo transfection experiments, it is not possible to distinguish whether the temperature shift directly affects the basal promoter requirement for
TAFII250 or reduces transcription indirectly through cell
cycle arrest. Indeed, previous studies have demonstrated that the rate
of transcription of class I genes is cell cycle
linked.2 To determine whether
inactivation of TAFII250 directly affects transcription of
class I, the ability of nuclear extracts from tsBN462 cells to direct
in vitro transcription of the promoter was tested. Extracts
were derived from cells grown either at 32 °C or at 39.5 °C and
were used to direct transcription from the Dependence on TAFII250 Maps to the Basal Promoter of
PD1--
Because the cellular promoter constructs tested contained
upstream activating sequences, the observed differential sensitivity among the promoters to the TAFII250 mutation in the tsBN462
cells could be either a reflection of differences in those upstream sequences or of differences in basal promoter architecture. To address
this question, the dependence on TAFII250 of a series of
nested 5'-truncations of the PD1 promoter was examined. The longest
promoter construct,
The full-length
In the pattern of its requirement for TAFII250, the PD1
promoter differs from the cyclin A promoter or the cyclin D1 promoter (6, 7). In the former case, an upstream ATF/CREB binding site has been
reported to function as a temperature-sensitive response element that
confers a dependence on TAFII250 (6). Like the cyclin A
promoter, the PD1 promoter contains a functional CRE that has been
demonstrated to bind and be activated by ATF/CREB family members (27).
However, unlike the cyclin A promoter, the presence of the CRE does not
increase the PD1 promoter dependence on TAFII250 (compare
Basal Promoter Elements Do Not Establish a Requirement for
TAFII250--
The above studies map TAFII250
dependence to the PD1 basal promoter, raising the question of whether
discrete basal promoter elements establish this requirement. A series
of promoter mutations were introduced into the PD1 basal promoter. In
one, the noncanonical TATAA box, TCTAA, was restored to a canonical
TATAA box (TCT>TATAAA); in another, it was mutated further away from
the canonical sequence (TATA M1). Both mutant promoters maintained the
requirement for a functional TAFII250 (Fig.
4). Thus, the presence of a TATAA box is
not sufficient to overcome the requirement for TAFII250. Similarly, the complete absence of a TATAA box does not increase the
dependence. A third mutant, in which the Inr was mutated (M3), also
retained its dependence on TAFII250 (Fig. 4).
Interestingly, a mutant construct in which both the TCTAA box and Inr
were mutated was active and remained dependent on TAFII250
(Fig. 4) (11). All of these promoter mutants retained significant
activity, both in the tsBN462 cells at the permissive temperature (Fig.
4) and in HeLa cells (11). An extended mutation of the entire central region between the TCTAA and Inr renders the promoter inactive (8); it
is inactive at both the permissive and restrictive temperatures in
tsBN462 cells. In summary, the class I TCTAA box and the Inr are
neither necessary nor sufficient for transcription initiation. Further,
no specific promoter element was identified that confers a dependence
on TAFII250.
Upstream Enhancers Can Confer Independence of TAFII250
on Basal Promoters--
The role of upstream enhancers in relieving
the basal promoter of its dependence on TAFII250 was
examined for the SV40 enhancer/promoter construct whose 72-bp repeat
enhancer has been extensively characterized. Removal of the two 72-bp
enhancer elements (leaving the 21-bp Sp1-binding GC repeats in place)
significantly reduces SV40 promoter activity; further removal of the
21-bp repeats eliminates all promoter activity. In the absence of the
72-bp enhancers, the activity of the SV40 promoter dropped 2-fold in
the tsBN462 cells at the restrictive temperature relative to the
permissive temperature, unlike the SV40 enhancer/promoter construct
which was activated by 2-fold (Fig. 5).
Thus, removal of the 72-bp enhancer markedly alters the promoter
sensitivity to functional TAFII250. These data are
consistent with the interpretation that the SV40 basal promoter is
inherently dependent upon TAFII250 but that the presence of
the enhancer elements overcomes this dependence. The ability of the
enhancers to alleviate TAFII250 dependence could be due either to a single subelement within the enhancer or to the cumulative effects of multiple enhancers. To distinguish between these
possibilities, the ability of a single enhancer and isolated
subelements to alter the TAFII250 dependence of the SV40
basal promoter was determined. As shown in Fig. 5, the introduction of
a single copy of the 72-bp enhancer element was sufficient to
completely protect the SV40 basal promoter from inhibition at the
restrictive temperature in tsBN462 cells. Furthermore, the individual
octamer or AP1 subelements were almost as effective as the whole 72-bp
element in restoring independence of TAFII250 to the SV40
basal promoter.
However, not all enhancer elements are capable of altering basal
promoter requirements. As seen in Fig. 5, the SV40 NF Coactivators and Activators Can Modulate the Class I Promoter
Requirement for TAFII250--
Because the SV40 enhancer
confers TAFII250 independence on the basal SV40 promoter,
we asked whether it could similarly rescue the heterologous PD1
promoter. A single SV40 72-bp enhancer was placed upstream of either
the
The ability of the heterologous viral enhancer element to overcome the
TAFII250 dependence of the class I promoter suggested that
endogenous activators might have similar activities. We recently reported that the helix-loop-helix factors, USF1 and USF2, are strong
activators of class I transcription in HeLa cells, binding to the
upstream E-box element (16). Therefore, we next asked whether either of
these activators could rescue the class I promoter from the requirement
for TAFII250. As shown in Table II, the class I
The above studies demonstrate that various upstream transcription
binding sites display differential abilities to protect the promoter
from the requirement for TAFII250. Because USF binds to the
class I E-box (16) but is unable to protect, this protection is not
simply a consequence of transcription factor binding to upstream
sequences. Therefore, we considered the possibility that rescue of
TAFII250 independence correlates with the recruitment of a
specific coactivator that can functionally replace
TAFII250. The class I promoter contains a CRE, which is not
regulated by the coactivators CBP and
p3003 but does mediate
transcriptional activation by the interferon-induced coactivator CIITA.
PD1 promoter activity is increased up to 15-fold in the presence of
CIITA.4 Therefore, the
ability of CIITA to activate the class I promoter and to rescue it from
TAFII250 dependence was assessed. As in other cell types,
CIITA activated the The requirements for initiation of transcription are still
incompletely understood. Although TBP and its associated TAFs clearly play important roles in nucleating the formation of the preinitiation complex, their precise functions appear to differ among different promoters. In the present study, we have examined the factors that
contribute to a promoter's requirement for TAFII250. We
have demonstrated that the basal promoter of class I requires
TAFII250 but that this requirement does not correlate with
the presence of a specific promoter element. Similarly, the activity of
the basal SV40 promoter depends on TAFII250. The
transcriptional requirement for TAFII250 can be overcome by
the presence of select upstream activators; CIITA, but not USF, rescued
the class I basal promoter, whereas Oct and Ap1 sites, but not NF The present studies begin to define the basis for promoter requirements
for TAFII250. It has been proposed previously that basal
promoters lacking a canonical TATAA box require a functional TAFII250 to nucleate the transcription apparatus either
directly or indirectly (7, 8). Indeed, the basal promoter of the PD1
promoter does not have a canonical TATAA box and requires functional
TAFII250. However, the related HLA-E promoter and the coordinately regulated Promoter dependence on TAFII250 also is unlikely to be a
simple reflection of basal promoter strength. The extended class I
promoter construct, The dependence on TAFII250 of both cellular and viral basal
promoters can be mitigated by some upstream regulatory elements. For
example, the basal class I promoter requires TAFII250, but significant reversal of this dependence is achieved by endogenous upstream sequences or by the introduction of the SV40 72-bp enhancer. Similarly, whereas the basal promoter of SV40 is dependent on TAFII250, the intact enhancer/promoter is not; its activity
actually increases at the restrictive temperature. Even the isolated
subelements of the viral enhancer, the octamer and the AP1 binding
sites, reduce the promoter's requirement for TAFII250.
Finally, modulation of TAFII250 dependence by upstream
sequences also has been observed in the cyclin genes (5-8). In one
case, removal of upstream sequences from the cyclin A promoter reduced
both promoter activity and its requirement for
TAFII250.
Not all elements known to regulate the downstream basal promoter affect
its dependence on TAFII250. In the present study, we have
shown that neither the NF The observed differences among upstream regulatory elements in
modulating dependence on TAFII250 may be determined by the transcription factors that associate with the elements and their different interactions with the preinitiation complex. The ATF/CREB family increases the dependence of the cyclin A promoter on
TAFII250 (6). Consistent with that finding, CBP/p300, which
are coactivators for ATF/CREB and function through the CRE element, do
not overcome class I promoter dependence on TAFII250 (data
not shown). However, significant reversal of the class I promoter
dependence is achieved by introduction of the CIITA coactivator, which
also targets the homologous CRE element.
One model to explain our observations is that activators that function
by interacting directly with TAFII250 fail to do so at the
restrictive temperature in the tsBN462 cells. On the other hand,
activators that do not interact with TAFII250 are able to overcome the dependence on TAFII250, possibly by replacing
TAFII250 function or by recruiting other coactivators. For
example, CIITA rescues the class I promoter from dependence on
TAFII250 and both Oct and AP1 rescue the SV40 promoter.
None of these factors is known to interact with TAFII250,
although they do interact with other components of TFIID (28-30). In
contrast, NF In conclusion, we have demonstrated that the TAFII250
requirements for transcription initiation not only differ among
different promoters, but can be modulated by upstream activators for a
given promoter. This observation raises the possibility that different preinitiation complexes initiate transcription of a given promoter, either in different tissues or in a single cell in response to dynamic
regulatory signals.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2-microglobulin, serve as receptors for viral peptides, thereby triggering a cellular immune response. Expression of the class I genes and
2-microglobulin genes are coordinately regulated
in vivo. Consistent with their role in immune surveillance
against intracellular pathogens, the class I and
2-microglobulin genes are expressed in nearly all somatic cells (9). However, the level of expression displays tissue-specific variation, which is further affected by hormonal signals. Although a complex array of upstream DNA elements modulates class I expression, the basal promoter itself is constitutively active
in the absence of any upstream activation (10, 11). The upstream
elements function primarily to modulate this basal level, resulting in
either increases or decreases, depending on the tissue and hormonal milieu.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2-microglobulin promoters.
2-microglobulin promoter contained 209 bp
of upstream sequence (18). The HLA-E promoter construct contained 155 bp of upstream sequence and was derived from the HLA 6.2 genomic clone
(19) by polymerase chain reaction and cloning into the
HindIII/BamHI sites of the pSV3CAT vector. The
enhancer/promoter SV40 constructs were as follows. pSV2, the
enhancer/promoter, and pSV3, the basal promoter construct, were as
described (20, 21). The SV40 enhancer subelement constructs were
generated by replacing SV40 sequences between the NdeI and
SphI sites of pSV3CAT with synthetic oligonucleotides, as
described previously (11). The 72-bp enhancer of the SV40 enhancer/promoter was isolated by SphI digestion and
introduced into the XbaI site of the class I
68 promoter
construct (11). Each of the promoters was ligated to the CAT reporter
gene; the HIVLTR was also ligated to luciferase. The CIITA expression
plasmid was provided by Dr. Jenny Ting, University of North Carolina
(22).
313 DNA, or 1 µg of cytomegalovirus (Promega) DNA and were
performed at 20 °C. Analysis of product was by primer extension
(12).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
2-microglobulin gene, which encodes the light chain that
associates with both of the class I heavy chains. All three promoter
constructs consisted of their basal promoter and upstream regulatory
elements. As shown in Table I, PD1
promoter activity in tsBN462 cells is markedly reduced at the
restrictive temperature, indicating that it depends on functional
TAFII250. The reduction in PD1 promoter activity is
specific to the tsBN462 mutation; in the parental BHK cells, the PD1
promoter construct
313CAT is 1.8 ± 0.5 times more active at
39.5 °C than at 32 °C. As shown in Fig.
1, cotransfection of wild type
TAFII250 with the class I promoter construct restored promoter activity in tsBN462 cells at the restrictive temperature. From
this, we conclude that the class I promoter depends upon TAFII250. Both the
2-microglobulin promoter
and the HLA-E promoter are similarly dependent on TAFII250.
Thus, among the three related promoters, all require
TAFII250.
Differential sensitivity to a TAFII250 mutation among different
promoters
313CAT); MHC class Ib,
nonclassical class I gene, HLA-E, with 80 bp of upstream sequences and
a canonical TATAA box;
2-microglobulin with 206 bp of
upstream sequence and a canonical TATAA box.

View larger version (11K):
[in a new window]
Fig. 1.
Exogenous TAFII250 restores class
I promoter activity in tsBN462 cells at the restrictive
temperature. tsBN462 cells were cotransfected with the class I
promoter construct,
313CAT, and increasing amounts of a
TAFII250 expression vector. Cells were incubated for
24 h at the permissive temperature, 32 °C, after which time
they were either shifted to the restrictive temperature, 39.5 °C, or
left at 32 °C for an additional 24 h before harvesting and
assaying for CAT activity. CAT activity is stable for at least 24 h at 39.5 °C in these cells (data not shown). The results are
presented as promoter activity at the restrictive temperature, relative
to the permissive, at each TAFII250 concentration.
2-microglobulin and HLA-E genes contain a canonical TATAA box but still require functional TAFII250 for
activity (Table I). Thus, there is no direct correlation between the
requirement for TAFII250 and the presence of a canonical
TATAA box in these cellular promoters.
313CAT class I promoter
construct. Extracts derived from cells grown at 32 °C were fully
competent to direct transcription from the class I promoter (Fig.
2, left). However, extracts
derived from cells grown at 39.5 °C were defective in transcribing
the same promoter (Fig. 2, left). In striking contrast,
in vitro transcription of the cytomegalovirus promoter
was increased in extracts prepared from cells grown at 39.5 °C,
relative to that prepared from cells grown at 32 °C (Fig. 2,
right). Because inhibition of class I promoter activity is
observed in a cell-free system, it is not secondary to the arrest at
G1 of cells following the shift to 39.5 °C.

View larger version (28K):
[in a new window]
Fig. 2.
In vitro transcription of the
class I promoter depends upon a functional TAFII250.
In vitro transcription assays on the class I promoter
construct,
313 (left) or the cytomegalovirus promoter
construct (right) were performed with extracts prepared from
tsBN462 cells grown at either 32 °C or 39.5 °C. The class
I-specific transcript is 67 bp, whereas the cytomegalovirus transcript
is 75 bp. The experimental lanes were derived from different parts of
the gel and have been aligned for the purposes of the figure.
1013, contains all of the upstream regulatory
elements necessary to determine normal patterns of expression of the
gene, as demonstrated in transgenic mice (10). Deletion of upstream
sequences between
1013 and
516 bp removes a series of silencer
elements and a complex regulatory element that governs tissue-specific
levels of expression (24) (Fig. 3).
Further truncations successively remove additional tissue-specific regulatory elements (
416), an E-box that is the target for USF activation (
313), enhancer A, the interferon-response element, and
the cAMP-responsive element (CRE) (
68) (16, 25, 26). The
68
promoter construct constitutes the basal promoter and contains only a
CCAAT box, a noncanonical TATAA box, an Inr, and an S-box important for
promoter function (11). Successive truncations between
1013 and
416
increase promoter activity (Fig. 3). It is important to note that,
unlike most basal promoters, the
68 promoter construct is
constitutively active and does not require upstream enhancers (Fig.
3).

View larger version (11K):
[in a new window]
Fig. 3.
TAFII250 dependence of the PD1
basal promoter is partially overcome by upstream activator
sequences. A nested series of truncation deletions of the extended
PD1 promoter was transfected into tsBN462 cells at 32 °C. After
24 h, cells were shifted to 39.5 °C or left at 32 °C for an
additional 24 h before harvesting and performing CAT assays.
Promoter activity at 32 °C compares the activity of each of the
constructs to the activity of the
313 constructs. The effect of
temperature is expressed as the relative promoter activity of a given
promoter at the restrictive and permissive temperatures and represents
the average of four independent experiments. TSE,
tissue-specific element; E, E-box sequence CACGTG;
A, enhancer A; IRE, interferon-response element,
CRE, cAMP-response element;
, basal promoter.
1013-bp promoter construct is active in the tsBN462
cells at the permissive temperature but is inhibited at the restrictive
temperature (Fig. 3). Each of the successive PD1 truncations from
1013 bp increases the promoter dependence on TAFII250
such that the
68-bp construct is approximately 3-fold more sensitive
than the
1013-bp construct, despite the fact that at 32 °C, it is
significantly more active than the
1013 bp construct (Fig. 3). Thus,
although the extended
1013 promoter is still sensitive to partial
inhibition at 39.5 °C, its upstream sequences confer a significant
level of protection on the basal promoter.
313-bp and
68-bp constructs). Thus, these findings also indicate
that ATF/CREB is not a general determinant of TAFII250 dependence.

View larger version (11K):
[in a new window]
Fig. 4.
Basal promoter dependence is not determined
by a specific promoter element. A series of mutations within the
basal promoter were introduced into either the class I construct,
416CAT (TATA M1, M3, M5), or the
68CAT construct (TCT>TATAA). Each
was then tested for its dependence on TAFII250 by
transfection into tsBN462 cells. The activity of the various promoter
mutants is compared with wild type at 32 °C. The effect of
temperature is presented as relative promoter activity of a given
mutant, at the restrictive and permissive temperatures, and represent
the average of four independent experiments.

View larger version (12K):
[in a new window]
Fig. 5.
The SV40 basal promoter is dependent on
TAFII250, but rescued by upstream enhancer elements.
The two 72-bp enhancers of the SV40 enhancer/promoter were removed by
AccI/SphI, to generate the basal promoter (11).
Individual enhancer elements were generated and introduced upstream of
the basal SV40 promoter, as described previously (11).
B element does
not protect the basal SV40 promoter from its dependence on TAFII250. This is true even in cells treated with phorbol
ester to activate nuclear translocation of NF
B (data not shown). The failure of the NF
B element to protect the promoter and the ability of the octamer and AP1 elements to protect do not reflect a
differential activation of the promoter by these elements; all three
isolated elements activate the promoter to the same extent (data not
shown). In addition, the GC-rich 21-bp Sp1 core promoter elements are also incapable of fully protecting the SV40 basal promoter from TAFII250 dependence. Because the SV40 promoter is inactive
in the absence of these 21-bp elements, it is not possible to determine whether they confer some level of protection on the promoter. Similarly, the central S box of the PD1 promoter, which is a binding site for, and is activated by, Sp1, is dependent on a functional TAFII250.
68-bp or
313-bp class I PD1 promoter constructs. In the
presence of the SV40 enhancer, class I promoter activity was markedly
increased. At the same time, the dependence of the class I promoter on
TAFII250 was significantly reduced (
68 construct) or
eliminated (
313 construct) (Table II).
Although neither the isolated octamer nor AP1 subelements was able to
fully protect the class I promoter, each did afford partial protection (data not shown). Therefore, the SV40 viral enhancer element is able to
alter the downstream promoter sensitivity to functional TAFII250, both on homologous and heterologous basal
promoters.
The SV40 72-bp enhancer can partially rescue the class I promoter from
dependence on TAFII250
68 and
313CAT, in the presence or
absence of the SV40 72-bp enhancer, were transfected into tsBN462 cells
at 32 °C. After 24 h, the cells were either shifted to
39.5 °C or left at 32 °C, for an additional 24 h before
harvesting and assaying for CAT activity. The enhancement is the
relative activity of the class I promoter in the presence or absence of
the enhancer, as measured at 32 °C. The relative activity is the
ratio of activity of a given promoter at the two temperatures. Results
are from representative experiments, each performed in triplicate.
416-bp
promoter construct, which contains an E-box, is activated by both USF1
and USF2 when co-transfected into tsBN462 cells maintained at 32 °C.
The levels of activation are markedly lower than observed in HeLa cells
(16). This is not a function of the TAFII250 mutation, because similarly low levels of USF activation are observed in the
parental BHK cells at 32 °C (data not shown). No protection of
promoter activity was observed by either USF1 or USF2. At 39.5 °C,
promoter activity is markedly inhibited even in the presence of either
USF1 or USF2 (Table III). USF1 and USF2
were active at both temperatures, as evidenced by the fact that each
efficiently activated a construct containing E-box elements upstream of
the AdML E1b promoter (Table III). Therefore, unlike the factors
associated with the SV40 enhancer, neither USF1 nor USF2 is able to
overcome the promoter requirement for TAFII250.
USF1 and USF2 fail to activate in the absence of a functional
TAFII250
313 and
416CAT) and U2E1b promoters, ligated to the
CAT reporter gene, were cotransfected with either an empty expression
vector or USF1 or USF2 cDNA-containing expression vector into
tsBN462 cells at 32 °C. After 24 h, cells were either left at
32 °C or shifted to 39.5 °C for an additional 16 h. The
class Ia PD1 promoter,
416CAT, contains 416 bp of upstream sequences;
313CAT contains 313 bp. The U2E1b promoter contains two copies of an
E-box element upstream of the AdML promoter.
313bp promoter in tsBN462 cells at 32 °C (Fig.
6). This activation depends on the
presence of the CRE element (
100 to
107 bp), because the
68-bp
promoter construct is not activated by CIITA (data not shown).
Dramatically, in the presence of CIITA, the class I promoter remains
active in the tsBN462 cells at the restrictive temperature (Fig. 6). Consistent with the finding that CBP/p300 do not regulate class I
promoter activity in fibroblasts, neither CBP nor p300 affected the
promoter requirement for TAFII250 (data not shown). From
these studies we conclude that upstream elements that recruit the
appropriate coactivators are capable of modulating the requirement for
TAFII250.

View larger version (20K):
[in a new window]
Fig. 6.
The coactivator, CIITA, can overcome the PD1
promoter requirement for TAFII250. A CIITA expression
vector, or control vector, was cotransfected with the PD1 promoter
construct,
313CAT, into tsBN462 cells at 32 °C. After 24 h,
the cells were shifted to 39.5 °C or left at 32 °C for an
additional 24 h before harvesting and assaying for CAT activity.
Promoter activity at each of the temperatures is shown.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
B,
rescued the SV40 basal promoter.
2-microglobulin promoter both
have canonical TATA boxes, yet both require TAFII250.
Furthermore, mutation of the PD1 basal promoter to introduce a
canonical TATAA box does not abrogate the promoter's dependence on
TAFII250. From these findings, we conclude that promoter
sequence elements do not determine the requirement for
TAFII250.
1013 CAT, is the least active of the constructs examined. Yet, it is also the least dependent on TAFII250.
The dependence of the basal SV40 promoter on TAFII250 is
overcome by the placing of either the AP1 or octamer elements upstream; both do increase promoter activity. However, the NF
B element also
enhances promoter activity and to the same extent; but it does not
affect the basal promoter dependence on TAFII250. In previous studies of the cyclin A promoter, demonstrating that upstream
elements conferred dependence on TAFII250, the basal promoter is only minimally active in the absence of upstream elements, so its dependence on TAFII250 is more difficult to assess
(6). Nevertheless, even in those studies, residual activity of the cyclin A promoter can be seen to drop 8-fold at the restrictive temperature in the temperature-sensitive cells (6). Taken together, the
data indicate that dependence on TAFII250 is unlikely to be a simple reflection of basal promoter strength. Indeed, it is likely
that all basal promoters depend on TAFII250, but the
magnitude of the dependence varies based on particular upstream
elements and the co-factors that they recruit.
B element of the SV40 promoter nor the
E-box of the class I promoter alters the downstream basal promoter
requirements. No obvious sequence features among the regulatory
elements have emerged from these studies to explain the differences in
their downstream effects.
B is known to interact with TAFII250 (31)
and is unable to overcome the requirement for TAFII250 of
the SV40 basal promoters. In support of this hypothesis, we have
demonstrated that the coactivator, CIITA, contains histone acetyltransferase activity and is able to replace the function of
TAFII250 on the class I
promoter.5 This leads to the
speculation that CIITA relieves the dependence on TAFII250
of the class I promoter by replacing its histone acetyltransferase activity. However, the presence of histone acetyltransferase activity alone is not sufficient, because CBP/p300 also has histone
acetyltransferase activity but does not rescue the promoter. Future
experiments, to test this prediction, are directed toward a molecular
characterization of CIITA rescue from the TAFII250 requirement.
| |
ACKNOWLEDGEMENTS |
|---|
We gratefully acknowledge Drs. Susan Kirshner, Aparna Raval, and Julie Lovchik for helpful discussions during the course of these studies. We also thank Drs. Fatah Kaschanchi, Shelby Berger, and Alfred Singer for critical review of the manuscript. We thank Josh Meyer for technical assistance.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: (301) 496-9097;
Fax: (301) 480-8499; E-mail: Dinah.Singer@nih.gov.
2 J. D. Weissman and D. S. Singer, unpublished observations.
3 J. D. Weissman, and S. Kirshner, unpublished observations.
4 A. Raval, S. Kirshner, and T. K. Howcroft, manuscript in preparation.
5 A. Raval, T. K. Howcroft, J. D. Weissman, S. Kirshner, J. Ting, and D. S. Singer, manuscript in preparation.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
TAF, TBP-associated
factor;
MHC, major histocompatibility complex;
bp, base pair(s);
CAT, chloramphenicol acetyltransferase;
HIV, human immunodeficiency virus;
LTR, long terminal repeat;
CRE, cAMP-responsive element;
CREB, cAMP-response element-binding protein;
NF
B, nuclear factor
B;
CBP, CREB-binding protein. AdML, adenovirus major late promoter.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Orphanides, G.,
Lagrange, T.,
and Reinberg, D.
(1996)
Genes Dev.
10,
2657-2683 |
| 2. | Verrijzer, C., Chen, J., Yokomori, K., and Tjian, R. (1995) Cell 81, 1115-1125[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Walker, S., Reese, J., Apone, L., and Green, M. (1996) Nature 383, 185-188[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Moqtaderi, Z., Bai, Y., Poo, D., Weil, P., and Struhl, K. (1996) Nature 383, 188-191[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Wang, E.,
and Tjian, R.
(1994)
Science
263,
811-814 |
| 6. |
Wang, E.,
Zhou, S.,
and Tjian, R.
(1997)
Genes Dev.
11,
2658-2669 |
| 7. | Suzuki-Yagawa, Guermah, M., and Roeder, R. (1997) Mol. Cell. Biol. 17, 3284-3294[Abstract] |
| 8. | Sekiguchi, T., Nishimoto, T., and Hunter, T. (1999) Oncogene 18, 1797-1806[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Singer, D. S., and Maguire, J. (1990) CRC Rev. Immunol. 10, 235-257 |
| 10. |
Maguire, J.,
Frels, W.,
Richardson, J.,
Weissman, J.,
and Singer, D.
(1992)
Mol. Cell. Biol.
12,
3078-3086 |
| 11. | Howcroft, T. K., Palmer, L., Brown, J., Rellahan, B., Kashanchi, F., Brady, J., and Singer, D. S. (1995) Immunity 3, 127-138[CrossRef][Medline] [Order article via Infotrieve] |
| 12. |
Weissman, J.,
Brown, J.,
Howcroft, T. K.,
Hwang, J.,
Chawla, A.,
Roche, P.,
Schiltz, L.,
Nakatani, Y.,
and Singer, D. S.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
11601-11606 |
| 13. | Hayashida, T., Sekiguchi, T., Noguchi, E., Sunamoto, H., Ohba, T., and Nishimoto, T. (1994) Gene (Amst.) 141, 267-270[CrossRef][Medline] [Order article via Infotrieve] |
| 14. | Nakashima, T., Sekiguchi, T., Sunamoto, H., Yura, K., Tomoda, S., Go, M., Kere, J., Schlessinger, D., and Nishimoto, T. (1994) Gene (Amst.) 141, 193-200[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Leonard, J.,
Parrot, C.,
Buckler-White, A.,
Turner, W.,
Ross, E.,
Martin, M.,
and Rabson, A.
(1989)
J. Virol.
63,
4919-4924 |
| 16. |
Howcroft, T. K.,
Huber, S.,
and Singer, D. S.
(1999)
Mol. Cell. Biol.
19,
4788-4797 |
| 17. |
Ehrlich, R.,
and Singer, D. S.
(1988)
Mol. Cell. Biol.
8,
695-703 |
| 18. | Carroll, I., Wang, J., Howcroft, T. K., and Singer, D. S. (1998) Mol. Immun. 35, 1171-1178 |
| 19. | Koller, B., Geraghty, D., Shimizu, Y., DeMars, R., and Orr, H. (1988) J. Immunol. 141, 897-907[Abstract] |
| 20. | Howcroft, T. K., Richardson, J., and Singer, D. S. (1993) EMBO J. 12, 3163-3169[Medline] [Order article via Infotrieve] |
| 21. |
Gorman, C.,
Moffat, L.,
and Howard, B.
(1982)
Mol. Cell. Biol.
2,
1044-1051 |
| 22. | Martin, B. K., Chin, C. K., Olsen, J. C., Skinner, C. A., Dey, A., Ozato, K., and Ting, J. P. (1997) Immunity 6, 591-600[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Dignam, J.,
Lebovitz, R.,
and Roeder, R.
(1983)
Nucleic Acids Res.
11,
1475-1489 |
| 24. |
Weissman, J.,
and Singer, D. S.
(1991)
Mol. Cell. Biol.
11,
4217-4227 |
| 25. |
Murphy, C.,
Nikodem, D.,
Howcroft, K.,
Weissman, J. D.,
and Singer, D. S.
(1996)
J. Biol. Chem.
271,
30992-30999 |
| 26. |
Saji, M.,
Moriarty, J.,
Ban, T.,
Kohn, L. D.,
and Singer, D.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1944-1948 |
| 27. |
Saji, M.,
Shong, M.,
Napolitano, G.,
Palmer, L.,
Taniguchi, S.,
Ohmori, M.,
Ohta, M.,
Suzuki, K.,
Kirshner, S.,
Giuliani, C.,
Singer, D. S.,
and Kohn, L. D.
(1997)
J. Biol. Chem.
272,
20096-20107 |
| 28. | Arnosti, D., Merino, A., Reingber, D., and Schaffner, W. (1993) EMBO J. 12, 157-166[Medline] [Order article via Infotrieve] |
| 29. | Franklin, C., McCulloch, A., and Kraft, A. (1995) Biochem. J. 305, 967-974 |
| 30. |
Zwilling, S.,
Annweiler, A.,
and Wirth, T.
(1994)
Nucleic Acids Res.
22,
1655-1662 |
| 31. |
Guermah, M.,
Malik, S.,
and Roeder, R.
(1998)
Mol. Cell. Biol.
18,
3234-3244 |
This article has been cited by other articles:
![]() |
A. Gegonne, J. D. Weissman, H. Lu, M. Zhou, A. Dasgupta, R. Ribble, J. N. Brady, and D. S. Singer TFIID component TAF7 functionally interacts with both TFIIH and P-TEFb PNAS, April 8, 2008; 105(14): 5367 - 5372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gegonne, J. D. Weissman, M. Zhou, J. N. Brady, and D. S. Singer TAF7: A possible transcription initiation check-point regulator PNAS, January 17, 2006; 103(3): 602 - 607. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, L. Wang, G. Buttice, P. K. Sengupta, and B. D. Smith Major Histocompatibility Class II Transactivator (CIITA) Mediates Repression of Collagen (COL1A2) Transcription by Interferon {gamma} (IFN-{gamma}) J. Biol. Chem., October 1, 2004; 279(40): 41319 - 41332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, L. Wang, G. Buttice, P. K. Sengupta, and B. D. Smith Interferon {gamma} Repression of Collagen (COL1A2) Transcription Is Mediated by the RFX5 Complex J. Biol. Chem., December 5, 2003; 278(49): 49134 - 49144. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Howcroft, A. Raval, J. D. Weissman, A. Gegonne, and D. S. Singer Distinct Transcriptional Pathways Regulate Basal and Activated Major Histocompatibility Complex Class I Expression Mol. Cell. Biol., May 15, 2003; 23(10): 3377 - 3391. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Raval, J. D. Weissman, T. K. Howcroft, and D. S. Singer The GTP-Binding Domain of Class II Transactivator Regulates Its Nuclear Export J. Immunol., January 15, 2003; 170(2): 922 - 930. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gegonne, J. D. Weissman, and D. S. Singer TAFII55 binding to TAFII250 inhibits its acetyltransferase activity PNAS, October 5, 2001; (2001) 211444798. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kirchner, S. L. Sanders, E. Klebanow, and P. A. Weil Molecular Genetic Dissection of TAF25, an Essential Yeast Gene Encoding a Subunit Shared by TFIID and SAGA Multiprotein Transcription Factors Mol. Cell. Biol., October 1, 2001; 21(19): 6668 - 6680. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsukihashi, M. Kawaichi, and T. Kokubo Requirement for Yeast TAF145 Function in Transcriptional Activation of the RPS5 Promoter That Depends on Both Core Promoter Structure and Upstream Activating Sequences J. Biol. Chem., July 6, 2001; 276(28): 25715 - 25726. [Abstract] [Full Text] [PDF] |
||||